ConductScience.org, home

Paper39335355

Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy.

Ishiguro T and 1 other. Brain Sci, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy. Papers, record 39335355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39335355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy.
PubMed
Journal
Brain Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.24, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishiguro TTakanobuhttps://orcid.org/0000-0002-8205-4912
2Kasuga KKensakuhttps://orcid.org/0000-0002-2178-0769

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JPMH24GB0101MHLW Research on Dementia ProgramPubMed

Source PubMed

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136832271CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias.Diagnostics (Basel)2023https://conductscience.org/library/papers/36832271PubMed
222526019CSF biomarkers cutoffs: the importance of coincident neuropathological diseases.Acta Neuropathol2012https://conductscience.org/library/papers/22526019PubMed
336153607Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease.Alzheimers Res Ther2022https://conductscience.org/library/papers/36153607PubMed
433581485Association of PSP phenotypes with survival: A brain-bank study.Parkinsonism Relat Disord2021https://conductscience.org/library/papers/33581485PubMed
525332445Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.Neurology2014https://conductscience.org/library/papers/25332445PubMed
631167811CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.J Neurol Neurosurg Psychiatry2019https://conductscience.org/library/papers/31167811PubMed
734385707Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.Nat Med2021https://conductscience.org/library/papers/34385707PubMed
828467028Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.Mov Disord2017https://conductscience.org/library/papers/28467028PubMed
929653606NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement2018https://conductscience.org/library/papers/29653606PubMed
108710059Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology1996https://conductscience.org/library/papers/8710059PubMed
1134961894CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles.Acta Neuropathol2022https://conductscience.org/library/papers/34961894PubMed
1233165511Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.JAMA Neurol2020https://conductscience.org/library/papers/33165511PubMed
1327068280CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.Lancet Neurol2016https://conductscience.org/library/papers/27068280PubMed
1420836136Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome.Mov Disord2011https://conductscience.org/library/papers/20836136PubMed
1528678775Cryo-EM structures of tau filaments from Alzheimer's disease.Nature2017https://conductscience.org/library/papers/28678775PubMed
1638678852Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study.Parkinsonism Relat Disord2024https://conductscience.org/library/papers/38678852PubMed
1735643092Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.Lancet Neurol2022https://conductscience.org/library/papers/35643092PubMed
1836508198Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.JAMA Neurol2023https://conductscience.org/library/papers/36508198PubMed
1932125724Copathology in Progressive Supranuclear Palsy: Does It Matter?Mov Disord2020https://conductscience.org/library/papers/32125724PubMed
2014107684PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.Arch Neurol1964https://conductscience.org/library/papers/14107684PubMed

See all 91 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42577438From clinical phenotypes to molecular precision: multimodal biomarkers for progressive supranuclear palsy.Front Neurosci2026https://conductscience.org/library/papers/42577438PubMed
41882788Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy.Transl Neurodegener2026https://conductscience.org/library/papers/41882788PubMed
41696714The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation?Front Mol Neurosci2026https://conductscience.org/library/papers/41696714PubMed
41170969The underlying causes of eye movement disorders and ataxia.Neurodegener Dis Manag2026https://conductscience.org/library/papers/41170969PubMed
40415873Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts.Alzheimers Dement (Amst)2025https://conductscience.org/library/papers/40415873PubMed
40282991Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative Review.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282991PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39335355

GET https://conductscience.org/api/papers/v1/39335355/references?page=2